#-supreme-cellcarta-differentiators-6-681{items-data:[{"text":"Platform-Agnostic Approach"},{"text":"20+ In-House Pathologists"},{"text":"Global Execution"},{"text":"AI-Powered Analysis"},{"text":"High-Touch Collaboration"}]}#-supreme-cellcarta-faq-10-681{items-data:[{"faq_question":"What digital pathology solutions do you offer?","faq_answer":"<p>Our digital pathology solutions cover the full tissue analysis workflow,including whole slide brightfield and fluorescent scanning,multispectral imaging,multiplex immunofluorescence,and advanced image analysis. Services are available as standalone digitization or as part of an end-to-end workflow,all performed in a CLIA-certified,CAP-accredited laboratory by a <a href=\"/capabilities/histopathology/pathology-team/\">dedicated team of pathologists</a> and imaging scientists.</p><p>Digital pathology solutions can also be combined with broader <a href=\"/capabilities/histopathology/\">histopathology</a> and <a href=\"/capabilities/histopathology/spatial-biology/\">spatial biology</a> services for a more complete tissue-based biomarker strategy.</p>"},{"faq_question":"What whole slide scanning technologies do you use?","faq_answer":"<p>CellCarta uses industry-standard whole slide scanning technologies from 3DHistech,Akoya,BioView,Leica Biosystems (Aperio®),Roche/Ventana,and Zeiss,enabling high-throughput,high-resolution brightfield and fluorescent imaging with fast turnaround times. Whole slide scanning is available as a standalone service for digitization programs or as part of an end-to-end digital pathology workflow.</p>"},{"faq_question":"How do you ensure consistency in image analysis across global sites?","faq_answer":"<p>Consistency is maintained through standardized SOPs,a rigorous internal pathology quality program,and the Pathotrainer platform,which supports scoring alignment,annotation,and continuing education across the global pathology network. Pathologists receive regular training in both novel and approved scoring methods from CDx developers,ensuring aligned scoring regardless of site.</p>"},{"faq_question":"How does AI feature in your digital pathology services?","faq_answer":"<p>AI is embedded across all of CellCarta's image analysis platforms,supporting nuclear segmentation,tissue classification,cell phenotyping,and circulating tumor cell detection. Our team offers expertise in developing and validating new AI-based algorithms for study-specific endpoints,and recently completed a global deployment of HALO AI to further advance quantitative image analysis capabilities across our digital pathology services.</p>"},{"faq_question":"Can you develop custom algorithms for our specific endpoints?","faq_answer":"<p>Yes. CellCarta's imaging scientists have expertise in developing and validating custom image analysis algorithms tailored to specific study endpoints. Our digital pathology platforms include HALO®,Visiopharm®,Lunit SCOPE®,inForm®,CyteHub®,and navify® by Roche,and our team can build bespoke algorithms or collaborate with your preferred digital pathology AI provider to apply their algorithms in clinical trial assays conducted at CellCarta.</p>"}]}#-supreme-cellcarta-partner-logos-22-707{padding-top:0px;padding-bottom:0px;selected-logos-data:[{"logo_id":"2922"},{"logo_id":"2924"},{"logo_id":"1472"},{"logo_id":"2926"},{"logo_id":"2928"},{"logo_id":"2930"},{"logo_id":"2932"}]}#-supreme-cellcarta-service-blocks-7-681{blocks-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/07/Histopathology-Services-hero-34.jpg","image_alt":"Histopathology services at CellCarta","title":"Histopathology","description":"End-to-end histopathology services from a team with deep clinical trial expertise across multiple indications.","button_text":"Discover","button_url":"/capabilities/histopathology/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Spatial-biology-platform-178.jpg","image_alt":"Spatial Biology services at CellCarta","title":"Spatial Biology","description":"Reveal how cells interact in their native tissue environment with spatial biology tools built for clinical research.","button_text":"Discover","button_url":"/capabilities/histopathology/spatial-biology/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta-73-Copy-scaled.jpg","image_alt":"IHC-IF services at CellCarta","title":"IHC-IF","description":"Tissue biomarker data from 200+ validated IHC and IF assays scored by board-certified pathologists.","button_text":"Discover","button_url":"/capabilities/histopathology/if-ihc/","button_target":"_self"}]}#-supreme-cellcarta-tab-content-4-681{oxy-supreme-cellcarta-tab-content-content-heading-tag:h3;oxy-supreme-cellcarta-tab-content-content-heading-size:default;oxy-supreme-cellcarta-tab-content-content-body-size:default;tabs-data:[{"tab_title":"Whole Slide Scanning","content_title":"","content_body":"<p>Access high-throughput,high-resolution imaging with fast turnaround times using industry-standard brightfield and fluorescent scanners from:</p>\n<ul>\n<li>3DHistech</li>\n<li>Akoya</li>\n<li>BioView</li>\n<li>Leica Biosystems (Aperio&reg;)</li>\n<li>RareCyte</li>\n<li>Roche/Ventana</li>\n<li>Zeiss</li>\n</ul>\n<p>Whole slide scanning is available as a standalone digitization service or as part of an end-to-end digital pathology workflow.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Whole-Slide-Scanning-Tab-699.jpg","image_alt":"Whole slide scanner in a CellCarta laboratory"},{"tab_title":"Advanced Image Analysis","content_title":"","content_body":"<p>Capture valuable data from tissues,such as cell phenotypes,densities,and spatial biology,using a broad portfolio of validated image analysis platforms,including:</p>\n<ul>\n<li><a href=\"/news/cellcarta-halo-ai-global-deployment/\" target=\"_self\">Indica Labs' HALO&reg;</a></li>\n<li>Lunit SCOPE&reg;suite</li>\n<li>Visiopharm&reg;</li>\n<li>Akoya's inForm&reg;</li>\n<li>CyteHub&reg;</li>\n<li>SoloWeb</li>\n<li>Navify&reg;by Roche</li>\n</ul>\n<p>In addition to running commercially validated assays,our scientists develop and validate custom algorithms to extract the specific information your clinical program needs.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Advanced-Image-Analysis-Tabb-731.jpg","image_alt":"Digital image analysis on a pathology slide"},{"tab_title":"AI-Powered Pathology","content_title":"","content_body":"<p>Achieve faster,more consistent tissue analysis with AI-powered image analysis,including for:</p>\n<ul>\n<li>Tissue segmentation classification</li>\n<li>Cell phenotyping</li>\n<li>Augmented pathologist scoring</li>\n<li>Quantitative continuous scoring</li>\n</ul>\n<p>We can implement and validate 3<sup>rd</sup> party algorithms or deploy commercial algorithms for all phases of clinical trials. We can also develop and validate new algorithms if your biomarker program requires.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/AI-Powered-Pathology-Tab-309.jpg","image_alt":"AI-powered pathology image analysis"},{"tab_title":"Expert Pathology Team","content_title":"","content_body":"<p>Benefit from a <a href=\"/capabilities/histopathology/pathology-team/\" target=\"_self\">specialist pathology team</a> with extensive experience in scoring a vast range of diagnostic assays in the context of clinical trials and biomarker testing.</p>\n<p>Our pathologists receive regular training in both novel and approved scoring methods from CDx developers,while an internal quality program delivers skills sharing and scoring alignment across the global network.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/07/Expert-Pathology-Team-tab-767.png","image_alt":"Expert pathologist reviewing digital slides"}]}